Items 451 to 460 of 465 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methyl (2S,4R)-1-(tert-butoxycarbonyl)-4-methylpyroglutamate | sc-218715 | 10 mg | $330.00 | |||
Methyl (2S,4R)-1-(tert-butoxycarbonyl)-4-methylpyroglutamate serves as a chiral reagent, notable for its ability to stabilize specific transition states through intramolecular interactions. The tert-butoxycarbonyl group provides steric protection, while the unique configuration of the pyroglutamate backbone facilitates selective binding to substrates. This configuration enhances the rate of enantioselective reactions, promoting the formation of targeted chiral products with improved efficiency. | ||||||
Methyl (2S)-1-tert-Boc-2,4,4-trimethylpyroglutamate | sc-218718 | 25 mg | $360.00 | |||
Methyl (2S)-1-tert-Boc-2,4,4-trimethylpyroglutamate acts as a chiral reagent, distinguished by its capacity to engage in dynamic stereoelectronic interactions. The tert-butoxycarbonyl moiety not only imparts steric hindrance but also influences the electronic environment, enhancing nucleophilicity. This compound's unique structural features enable it to effectively modulate reaction pathways, leading to accelerated enantioselective transformations and improved selectivity in asymmetric synthesis. | ||||||
N-[(R)-(+)-1-Phenylethyl]imidazole-1-carboxamide | sc-218986 | 1 g | $360.00 | |||
N-[(R)-(+)-1-Phenylethyl]imidazole-1-carboxamide serves as a chiral reagent, characterized by its ability to form strong hydrogen bonds and engage in π-π stacking interactions due to its aromatic structure. This compound's imidazole ring enhances its reactivity, facilitating selective pathways in asymmetric reactions. Its unique stereochemical configuration promotes favorable transition states, leading to enhanced enantioselectivity and improved reaction kinetics in various synthetic applications. | ||||||
N-Boc-4-dimethyl-L-glutamic Acid | sc-219079 | 10 mg | $300.00 | |||
N-Boc-4-dimethyl-L-glutamic Acid is a versatile chiral reagent known for its ability to stabilize transition states through intramolecular hydrogen bonding. The bulky N-Boc protecting group enhances steric hindrance, promoting selectivity in asymmetric synthesis. Its unique side chain facilitates specific molecular interactions, allowing for tailored reactivity in various catalytic processes. This compound's distinct stereochemical properties contribute to its effectiveness in generating enantiomerically enriched products. | ||||||
N-Hydroxy Tipranavir | sc-219160 | 1 mg | $430.00 | |||
N-Hydroxy Tipranavir serves as a chiral reagent characterized by its ability to form stable complexes with metal catalysts, enhancing enantioselectivity in reactions. Its hydroxyl group participates in hydrogen bonding, influencing reaction pathways and kinetics. The compound's unique steric and electronic properties allow for selective interactions with substrates, facilitating the formation of chiral centers. This behavior makes it a valuable tool in asymmetric synthesis, promoting the generation of diverse chiral compounds. | ||||||
N-Trifluoroacetodidemethylcitalopram | sc-219248 | 2.5 mg | $380.00 | |||
N-Trifluoroacetodidemethylcitalopram acts as a chiral reagent, notable for its strong electrophilic nature due to the trifluoroacetyl group. This feature enhances its reactivity in nucleophilic substitution reactions, allowing for selective formation of chiral intermediates. The compound's unique steric hindrance and electron-withdrawing properties influence reaction dynamics, promoting specific pathways that favor the generation of enantiomerically enriched products. Its distinct interactions with nucleophiles make it a significant player in asymmetric synthesis. | ||||||
N-Trityl Candesartan Trityl Ester | sc-219263 | 5 mg | $360.00 | |||
N-Trityl Candesartan Trityl Ester serves as a chiral reagent characterized by its unique trityl groups, which provide substantial steric bulk and electronic effects. This configuration facilitates selective interactions with nucleophiles, enhancing the formation of chiral centers through asymmetric pathways. The compound's ability to stabilize transition states and influence reaction kinetics makes it a valuable tool in the synthesis of enantiomerically pure compounds, showcasing its role in advancing chiral chemistry. | ||||||
(R)-(+)-5′-Hydroxyphenyl Carvedilol | sc-219728 | 1 mg | $380.00 | |||
(R)-(+)-5'-Hydroxyphenyl Carvedilol acts as a chiral reagent, distinguished by its specific stereochemistry and functional groups that promote unique molecular interactions. Its hydroxyl and phenyl moieties enhance hydrogen bonding and π-π stacking, influencing reaction pathways and selectivity. This compound exhibits notable reactivity in asymmetric synthesis, where its chiral environment can effectively modulate transition state energies, leading to the preferential formation of desired enantiomers. | ||||||
(R)-5-Ethylcarboxyl-N-acetyl-2-pyrrolidinone | sc-219740 | 2.5 g | $360.00 | |||
(R)-5-Ethylcarboxyl-N-acetyl-2-pyrrolidinone serves as a chiral reagent characterized by its unique pyrrolidinone ring, which facilitates specific steric and electronic interactions. The presence of the ethylcarboxyl and N-acetyl groups enhances its ability to stabilize transition states, promoting regioselectivity in reactions. Its distinct conformational flexibility allows for tailored interactions with substrates, optimizing reaction kinetics and improving enantioselectivity in asymmetric transformations. | ||||||
(R)-9-[2-Benzyloxypropyl)-N6-benzoyl Adenine | sc-219744 | 10 mg | $430.00 | |||
(R)-9-[2-Benzyloxypropyl)-N6-benzoyl Adenine is a chiral reagent notable for its unique adenine core, which enables specific hydrogen bonding and π-π stacking interactions. The benzyloxypropyl substituent introduces steric hindrance, influencing the orientation of substrates during reactions. This compound exhibits remarkable selectivity in catalytic processes, enhancing enantioselectivity through its ability to stabilize chiral transition states, thus optimizing reaction pathways and kinetics. | ||||||